1. Academic Validation
  2. A systematic protocol for the characterization of Hsp90 modulators

A systematic protocol for the characterization of Hsp90 modulators

  • Bioorg Med Chem. 2011 Jan 1;19(1):684-92. doi: 10.1016/j.bmc.2010.10.029.
Robert L Matts 1 Gary E L Brandt Yuanming Lu Anshuman Dixit Mehdi Mollapour Suiquan Wang Alison C Donnelly Leonard Neckers Gennady Verkhivker Brian S J Blagg
Affiliations

Affiliation

  • 1 Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK 74078, United States.
Abstract

Several HSP90 modulators have been identified including the N-terminal ligand geldanamycin (GDA), the C-terminal ligand novobiocin (NB), and the co-chaperone disruptor celastrol. Other HSP90 modulators elicit a mechanism of action that remains unknown. For example, the natural product gedunin and the synthetic anti-spermatogenic agent H2-gamendazole, recently identified HSP90 modulators, manifest biological activity through undefined mechanisms. Herein, we report a series of biochemical techniques used to classify such modulators into identifiable categories. Such studies provided evidence that gedunin and H2-gamendazole both modulate HSP90 via a mechanism similar to celastrol, and unlike NB or GDA.

Figures